Vanguard Group’s Moleculin Biotech MBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.34K | Hold |
30,935
| – | – | ﹤0.01% | 4264 |
|
|
2025
Q1 | $30.1K | Hold |
30,935
| – | – | ﹤0.01% | 4227 |
|
|
2024
Q4 | $52.6K | Sell |
30,935
-40,468
| -57% | -$68.8K | ﹤0.01% | 4211 |
|
|
2024
Q3 | $203K | Sell |
71,403
-13,015
| -15% | -$37K | ﹤0.01% | 4142 |
|
|
2024
Q2 | $297K | Buy |
84,418
+9,118
| +12% | +$32.1K | ﹤0.01% | 4101 |
|
|
2024
Q1 | $445K | Sell |
75,300
-1,004,822
| -93% | -$5.94M | ﹤0.01% | 4046 |
|
|
2023
Q4 | $927K | Hold |
1,080,122
| – | – | ﹤0.01% | 3851 |
|
|
2023
Q3 | $462K | Hold |
1,080,122
| – | – | ﹤0.01% | 4072 |
|
|
2023
Q2 | $625K | Hold |
1,080,122
| – | – | ﹤0.01% | 4056 |
|
|
2023
Q1 | $1.04M | Hold |
1,080,122
| – | – | ﹤0.01% | 3905 |
|
|
2022
Q4 | $1.14M | Buy |
1,080,122
+600
| +0.1% | +$636 | ﹤0.01% | 3861 |
|
|
2022
Q3 | $1.14M | Hold |
1,079,522
| – | – | ﹤0.01% | 3961 |
|
|
2022
Q2 | $1.57M | Hold |
1,079,522
| – | – | ﹤0.01% | 3920 |
|
|
2022
Q1 | $1.92M | Sell |
1,079,522
-8,197
| -0.8% | -$14.6K | ﹤0.01% | 3975 |
|
|
2021
Q4 | $2.02M | Buy |
1,087,719
+34,657
| +3% | +$64.5K | ﹤0.01% | 4036 |
|
|
2021
Q3 | $3.16M | Buy |
1,053,062
+5,533
| +0.5% | +$16.6K | ﹤0.01% | 3892 |
|
|
2021
Q2 | $3.84M | Buy |
1,047,529
+579,025
| +124% | +$2.12M | ﹤0.01% | 3726 |
|
|
2021
Q1 | $1.91M | Sell |
468,504
-123,450
| -21% | -$504K | ﹤0.01% | 3870 |
|
|
2020
Q4 | $472K | Sell |
591,954
-34,022
| -5% | -$27.1K | ﹤0.01% | 3961 |
|
|
2020
Q3 | $509K | Sell |
625,976
-920,187
| -60% | -$748K | ﹤0.01% | 3813 |
|
|
2020
Q2 | $1.5M | Sell |
1,546,163
-1,104,841
| -42% | -$1.07M | ﹤0.01% | 3517 |
|
|
2020
Q1 | $1.62M | Buy |
2,651,004
+48,890
| +2% | +$29.8K | ﹤0.01% | 3356 |
|
|
2019
Q4 | $2.38M | Sell |
2,602,114
-246
| -0% | -$225 | ﹤0.01% | 3400 |
|
|
2019
Q3 | $2.89M | Sell |
2,602,360
-77,650
| -3% | -$86.2K | ﹤0.01% | 3321 |
|
|
2019
Q2 | $3.35M | Buy |
2,680,010
+1,880,961
| +235% | +$2.35M | ﹤0.01% | 3307 |
|
|
2019
Q1 | $647K | Buy |
799,049
+110,728
| +16% | +$89.7K | ﹤0.01% | 3727 |
|
|
2018
Q4 | $716K | Buy |
688,321
+22,380
| +3% | +$23.3K | ﹤0.01% | 3656 |
|
|
2018
Q3 | $1.07M | Buy |
665,941
+5,483
| +0.8% | +$8.78K | ﹤0.01% | 3702 |
|
|
2018
Q2 | $1.18M | Buy |
660,458
+114,036
| +21% | +$204K | ﹤0.01% | 3645 |
|
|
2018
Q1 | $984K | Buy |
546,422
+86,780
| +19% | +$156K | ﹤0.01% | 3651 |
|
|
2017
Q4 | $855K | Buy |
459,642
+33,555
| +8% | +$62.4K | ﹤0.01% | 3643 |
|
|
2017
Q3 | $1.02M | Buy |
426,087
+88,766
| +26% | +$212K | ﹤0.01% | 3587 |
|
|
2017
Q2 | $631K | Buy |
337,321
+73,161
| +28% | +$137K | ﹤0.01% | 3683 |
|
|
2017
Q1 | $309K | Buy |
264,160
+246,202
| +1,371% | +$288K | ﹤0.01% | 3834 |
|
|
2016
Q4 | $41K | Buy |
+17,958
| New | +$41K | ﹤0.01% | 4044 |
|